Skip to content

Clinical trials

Phase 3 Respiratory Tract Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 3 Country / region: Germany Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20111
20132
20145
20152
20163
20172
20183
20192
20203
20221
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting4
Terminated4
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca11
Medicago2
Merck Sharp & Dohme LLC2
United Therapeutics2
Vertex Pharmaceuticals Incorporated2
Bellus Health Inc. - a GSK company1
Daiichi Sankyo1
Eli Lilly and Company1
GlaxoSmithKline1
Grifols Therapeutics LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases29
Lung Diseases22
Lung Diseases, Obstructive12
Bronchial Diseases11
Asthma10
Pathologic Processes5
Respiratory Tract Infections4
Carcinoma, Non-Small-Cell Lung3
Chronic Cough3
Cough3

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.